Sort
82,697 grants matching “vaccine development”
Env evolution in humans and RMs
$1,097,115George M Shaw · University Of Pennsylvania · P01 · FY2020 · AI
Addressing COVID-19 Testing Disparities in Vulnerable Populations Using a Community JITAI (Just in Time Adaptive Intervention) Approach: RADxUP Phase III
$1,096,924Maria Eulalia Fernandez · University Of Texas Hlth Sci Ctr Houston · U01 · FY2023 · TR
Virus Ecology Unit - COVID-19 response
$1,096,841Vincent Munster · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Pathophysiological Actions of Anthrax Virulence Determinants
$1,096,760Stephen Leppla · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Optimizing combination therapy for Hepatitis C virus with pharmacodynamic models
$1,096,497Ashley Brown · University Of Florida · R01 · FY2018 · AI
Development of Enabling Vector/Antigen Expression Technology for an Orally-Delive
$1,096,039B. Kim Lee Sim · Protein Potential, Llc · R01 · FY2016 · AI
Genetic Risk Variants in Atopic Dermatitis Associated with Eczema Herpeticum
$1,095,670Donald Ym Leung · National Jewish Health · U19 · FY2015 · AI
Harvard Medical School Vaccine Clinical Trials Unit
$1,095,523Raphael Dolin · Beth Israel Deaconess Medical Center · UM1 · FY2012 · AI
Breaking the Barrier to an HIV Vaccine
$1,095,500Sara Sawyer · University Of Colorado · DP1 · FY2022 · AI
Breaking the Barrier to an HIV Vaccine
$1,095,500Sara Sawyer · University Of Colorado · DP1 · FY2024 · AI
Breaking the Barrier to an HIV Vaccine
$1,095,500Sara Sawyer · University Of Colorado · DP1 · FY2025 · AI
Breaking the Barrier to an HIV Vaccine
$1,095,500Sara Sawyer · University Of Colorado · DP1 · FY2023 · AI
WaNPRC MACACA NEMESTRINA SPF BREEDING COLONY
$1,095,130David M Anderson · University Of Washington · U24 · FY2006 · RR
Medicinal Chemistry Optimization of Anti-Alphaviral Leads and Elucidation of Target and Off Target Engagement
$1,095,000Jennifer E. Golden · University Of Tennessee Health Sci Ctr · U19 · FY2019 · AI
Johns Hopkins University-Guangxi, China Clinical Trials Unit
$1,094,909Jay B Jackson · Johns Hopkins University · U01 · FY2009 · AI
University of Rochester HIV/AIDS Clinical Trials Unit Administrative Supplement
$1,094,709Michael C Keefer · University Of Rochester · UM1 · FY2025 · AI
Development Of New Approaches To Vaccines Against TBEV and West Nile Virus
$1,094,394Alexander Pletnev · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Broad Spectrum Neutralizing Human Abs to SARS and Related Coronaviruses
$1,093,892Wayne A. Marasco · Dana-Farber Cancer Inst · R01 · FY2010 · AI
Env evolution in humans and RMs
$1,093,737George M Shaw · University Of Pennsylvania · P01 · FY2021 · AI
San Francisco Bay Clinical Trials Unit (CTU)
$1,093,620Susan Buchbinder · Public Health Foundation Enterprises · UM1 · FY2025 · AI
An Advanced Vaccine Candidate To Prevent Zika Virus Infection
$1,093,491Mark K Slifka · Oregon Health & Science University · R01 · FY2020 · AI
Cellular Responses
$1,093,465David B. Weiner · Wistar Institute · U19 · FY2018 · AI
Coxiella burnetii immunobiology, host-pathogen modeling, and countermeasure development
$1,093,217Carrie Mae Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
STING agonist-expressing BCG for bladder cancer
$1,092,982Todd Wallach · Oncosting Llc · R44 · FY2023 · CA
HORMONAL CONTRACEPTON & RISK OF HIV ACQUISITION
$1,092,727Family Health International · N01 · FY2009 · HD